A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

19.8K views

⸱

DOI:

10.3791/56420

⸱

December 27th, 2017

 ,  ,  , 

In This Article

Summary

A highly pure population of megakaryocytes can be obtained from cord blood-derived CD34+ cells. A method for CD34+ cell isolation and megakaryocyte differentiation is described here.

Abstract

Platelet production occurs principally in the bone marrow in a process known as thrombopoiesis. During thrombopoiesis, hematopoietic progenitor cells differentiate to form platelet precursors called megakaryocytes, which terminally differentiate to release platelets from long cytoplasmic processes termed proplatelets. Megakaryocytes are rare cells confined to the bone marrow and are therefore difficult to harvest in sufficient numbers for laboratory use. Efficient production of human megakaryocytes can be achieved in vitro by culturing CD34+ cells under suitable conditions. The protocol detailed here describes isolation of CD34+ cells by magnetic cell sorting from umbilical cord blood samples. The necessary steps to produce highly pure, mature megakaryocytes under serum-free conditions are described. Details of phenotypic analysis of megakaryocyte differentiation and determination of proplatelet formation and platelet production are also provided. Effectors that influence megakaryocyte differentiation and/or proplatelet formation, such as anti-platelet antibodies or thrombopoietin mimetics, can be added to cultured cells to examine biological function.

Introduction

Isolation of adequate numbers of primary human megakaryocytes (MK) for regular laboratory use is not feasible due to their low frequency in the bone marrow, where they account for ~0.01% of nucleated cells1. A convenient alternative is the ex vivo expansion and differentiation of hematopoietic stem and progenitor cells in the presence of specific growth factors. A number of cytokines including stem cell factor (SCF; c-kit ligand) and interleukin (IL)-3 and IL-11 have been employed in culture systems to produce MKs. Thrombopoietin (TPO) is the most effective growth and differentiation factor for megakaryocytic cultures and is effective ....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol was approved by the South Eastern Sydney Human Research Ethics Committee and ratified by the University of New South Wales' Human Research Ethics Committee. Umbilical cord blood obtained from healthy donors was provided by the Sydney Cord Blood Bank (Sydney, NSW, Australia). Volumes of approximately 100 mL were used for this procedure.

NOTE: Work in a Class II biosafety cabinet using aseptic technique. Decontaminate the exterior of the cord blood bag with 70% ethanol. Use sterile instruments (scissors, tweezers) for this procedure.

1. Cord Blood Cell Preparation and Isolation of CD34+ C....

Access restricted. Please log in or start a trial to view this content.

Results

This protocol allows the preparation of highly pure MK cultures from cord blood-derived CD34+ cells. The percentage of CD34+ cells in cord blood is approximately 1.3%15 (Figure 1A) and the total number of mononuclear cells (step 1.8) ranges from 90 - 300 x 106 per UCB unit. The purity of CD34+/CD45+ cells after isolation ranges from 90 to 99% (Figure 1B). MK (defined as CD4.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol described here is suitable for consistent production of MK and platelets in culture from umbilical cord blood. These cells can be used to study various processes such as the effect of drugs or biological activities on MK proliferation, differentiation, proplatelet formation, and platelet production.

A variety of culture media and cytokine combinations have been presented in the literature. Addition of cytokines such as stem cell factor, Flt-3 ligand, IL-3, and IL-6 supports CD34

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors acknowledge the support of the Australian Health and Medical Research Council (project grant 1012409 linked to BHC).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Cell Culture Reagents
Recombinant Human TPOMiltenyi Biotec130-094-013
StemSpan SFEM IIStem Cell Technologies9605Serum-free media for CD34+ cells
NameCompanyCatalog NumberComments
CD34 Isolation Reagents
CD34 MicroBead kit ultrapureMiltenyi Biotec130-100-453This kit includes the FcR human IgG blocking reagent and CD34 microbeads. These beads contain the anti-CD34 antibody clone QBEND/10. Use a different anti-CD34 clone for purity check (e.g. clone 8G12).
LymphoprepAlere Technologies1114545Lymphocyte separation media (density 1.077 g/mL)
Sterile separation buffer (SB)Miltenyi Biotec130-091-221This buffer contains phosphate buffered saline (PBS), pH 7.2 containing 0.5% bovine serum albumin and 2 mM EDTA. It can be prepared using sterile, cell culture grade components. De-gas before use because air bubbles can block the column.
NameCompanyCatalog NumberComments
Flow Cytometry and Cell Staining Reagents
PE Mouse anti-Human CD34BD Biosciences340669Clone 8G12. This can be used for CD34 purity check. Final antibody concentration 1:10 dilution.
PerCP mouse anti-human CD45BD Biosciences3474641:10 dilution
PerCP isotype controlBD Biosciences3490441:10 dilution
FITC Mouse anti-Human CD41aBD Biosciences340929Final antibody concentration 1:5 dilution.
APC Mouse anti-Human CD42bBD Biosciences551061This antibody can also be used to detect mature MK (the percentage of positive cells in usually lower than with anti CD42a). Final antibody concentration 1:10 dilution.
Alexa Fluor 647 Mouse anti-Human CD42aAbD SerotecMCA1227A647TCurrently distributed by Bio-Rad. Final antibody concentration 1:10 dilution.
Alexa Fluor 647 Mouse Negative ControlAbD SerotecMCA928A647Currently distributed by Bio-Rad. Isotype control antibody
Anti von Willebrand factor rabbit polyclonalAbcamAB69941:200 dilution
V450 mouse anti-humna CD41aBD Biosciences584251: 20 dilution
V450 isotype controlBD Biosciences5803731:20 dilution
PAC1-FITC antibodyBD Biosciences3405071:10 dilution
Anti CD62p mouse monoclonalAbcamAB66321:200 dilution
Alexa Fluor 488 goat anti rabbit IgGInvitrogenA110081:100 dilution
Alexa Fluor 594 goat anti mouse IgGInvitrogenA110201:100 dilution
Ig Isotype Control cocktail-CBD Biosciences558659Isotype control antibody
Propidium iodideSigma AldrichP4864
CountBright Absolute Counting BeadsMolecular Probes, InvitrogenC36950Counting beads
NameCompanyCatalog NumberComments
Materials
LS columnsMiltenyi Biotec130-042-401Smaller and larger columns are also commercially available
MidiMACS Separator magnetMiltenyi Biotec130-042-302
MACS MultiStandMiltenyi Biotec130-042-303
Falcon 5mL round bottom polypropylene FACS tubes, with Snap Cap, SterileIn Vitro technologies352063
Glass slidesMenzel-GlaserJ3800AMNZ
Mounting media with DAPIVector LaboratoriesH-1200Antifade mounting medium with DAPI
NameCompanyCatalog NumberComments
Equipment
Inverted microscopeLeicaDMIRB inverted microscope
Fluorescent microscopeZeissVert.A1
Cell analyserBD BiosciencesFACS Canto II
Cytospin centrifugeThermoScientificCytospin 4
NameCompanyCatalog NumberComments
Software
Cell analyser softwareBD BiosciencesFACS Diva Software
Single cell analysis softwareTree StarFlowJo
Fluorescent microscope softwareZeissZen 2 blue edition

References

  1. Nakeff, A., Maat, B. Separation of megakaryocytes from mouse bone marrow by velocity sedimentation. Blood. 43 (4), 591-595 (1974).
  2. Zeigler, F. C., et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-m....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

CD34-positive CellsCord Blood IsolationMagnetic Cell SortingFlow CytometryProplatelet FormationSerum-free CultureThrombopoietin SupplementationFluorescent Microscopy